I’m sure a lot of folks are wishing they hadn’t bothered.
By Damian Paletta and Yasmeen Abutaleb Washington Post
If Azar could get the drug, what would the White House need to do to make that happen? Azar thought for a moment. It was Oct. 1, 2020, and the drug was still in clinical trials. The Food and Drug Administration would have to make a “compassionate use” exception for its use since it was not yet available to the public. Only about 10 people so far had used it outside of those trials. Azar said of course he would help.
Azar wasn’t told who the drug was for but would later connect the dots. The patient was one of President Donald Trump’s closest advisers: Hope Hicks.